Credit Suisse Ag Rhythm Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 43,164 shares of RYTM stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,164

Previous 42,012 2.74%

Holding current value

$1.76 Million

Previous $1.93 Million 3.16%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$39.12 - $52.44 $45,066 - $60,410	1,152 Added 2.74%	43,164 $1.87 Million
Q4 2023 Feb 08, 2024	SELL	$21.39 - $49.64 $27,935 - $64,829	-1,306 Reduced 3.01%	42,012 $1.93 Million
Q3 2023 Nov 13, 2023	SELL	$15.81 - $27.8 $406,048 - $713,987	-25,683 Reduced 37.22%	43,318 $992,000
Q2 2023 Aug 11, 2023	BUY	$16.32 - $21.15 $223,747 - $289,966	13,710 Added 24.8%	69,001 $1.14 Million
Q1 2023 May 10, 2023	BUY	$16.88 - $34.24 $132,997 - $269,776	7,879 Added 16.62%	55,291 $986,000

Q4 2022 Feb 13, 2023	BUY	$22.25 - $30.25 $265,398 - $360,822	11,928 Added 33.62%	47,412 $1.38 Million
Q3 2022 Nov 10, 2022	BUY	$4.3 - $30.85 $47,136 - $338,177	10,962 Added 44.7%	35,484 $869,000
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $8,576 - $33,675	-2,749 Reduced 10.08%	24,522 $102,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $7,024 - $14,027	-1,146 Reduced 4.03%	27,271 $314,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $24,454 - $39,434	2,837 Added 11.09%	28,417 $283,000
Q3 2021 Nov 12, 2021	BUY	$11.68 - $20.72 $20,767 - $36,840	1,778 Added 7.47%	25,580 $335,000
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $30,632 - $37,297	-1,654 Reduced 6.5%	23,802 $467,000
Q1 2021 May 14, 2021	SELL	$20.25 - $39.49 $381,105 - $743,201	-18,820 Reduced 42.51%	25,456 $541,000
Q4 2020 Feb 12, 2021	BUY	$21.17 - $32.61 $576,162 - $887,513	27,216 Added 159.53%	44,276 $1.32 Million
Q3 2020 Nov 13, 2020	SELL	$18.13 - $30.61 $362,473 - $611,985	-19,993 Reduced 53.96%	17,060 $369,000
Q2 2020 Aug 12, 2020	BUY	$14.41 - $25.35 $330,205 - $580,895	22,915 Added 162.08%	37,053 $826,000
Q1 2020 May 13, 2020	SELL	$13.16 - $22.9 $13,344 - $23,220	-1,014 Reduced 6.69%	14,138 $215,000
Q4 2019 Feb 12, 2020	BUY	$19.53 - $25.5 $75,112 - $98,073	3,846 Added 34.02%	15,152 $347,000
Q3 2019 Nov 12, 2019	SELL	$18.62 - $24.51 $53,569 - $70,515	-2,877 Reduced 20.28%	11,306 $244,000
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $98,119 - $132,375	4,648 Added 48.75%	14,183 $311,000
Q1 2019 May 14, 2019	BUY	$24.76 - $31.66 $21,169 - $27,069	855 Added 9.85%	9,535 $261,000
Q4 2018 Feb 13, 2019	SELL	$24.11 - $31.34 $175,279 - $227,841	-7,270 Reduced 45.58%	8,680 $233,000
Q3 2018 Nov 13, 2018	BUY	$26.99 - $35.85 $193,086 - $256,470	7,154 Added 81.33%	15,950 $466,000
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $149,707 - $309,619	8,796 New	8,796 $275,000

Others Institutions Holding RYTM

# of Institutions

176

Shares Held

62.4M

Call Options Held

880K

Put Options Held

84.1K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.27B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account